• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Women Health Disease Diagnosis Treatment Market

    ID: MRFR/MED/0771-HCR
    115 Pages
    Kinjoll Dey
    September 2025

    Women Health Disease Diagnosis & Treatment Market Research Report Information, by Type (Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, Osteoporosis), End users (Hospitals, clinics, diagnostic centers) - Forecast to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Women Health Disease Diagnosis Treatment Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Women Health Disease Diagnosis Treatment Market Summary

    The Global Women Health Disease Diagnosis and Treatment Market is projected to grow significantly from 30.4 USD Billion in 2024 to 70.5 USD Billion by 2035.

    Key Market Trends & Highlights

    Women Health Disease Diagnosis and Treatment Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 7.95 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 70.5 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 30.4 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of women's health issues is a major market driver.

    Market Size & Forecast

    2024 Market Size 30.4 (USD Billion)
    2035 Market Size 70.5 (USD Billion)
    CAGR (2025-2035) 7.95%

    Major Players

    General Electric Company, HRA Pharma, CooperSurgical Inc., Rinovum Women’s Health LLC, ASCEND Therapeutics, Hologic Inc., Genetic Technologies Limited, Mylab Discovery Solutions, Terumo Aortic, Lia

    Women Health Disease Diagnosis Treatment Market Trends

    Drivers some of the women’s centric diseases include breast cancer, menopause, and many more. As per World Health Organization, it was noted that breast cancer is the main cause of the development of market size and market growth. 2.1million women face breast cancer due to which the cancer rate has been extended to a high height. The research organizations of the women health disease diagnosis market and women health disease treatment market have conducted various programs and campaigns that have helped in striking up the market growth at a high rate. Opportunities some of the other women-related disorders like anemia and osteoporosis have helped in rising the growth and the demand for diagnosis-related products which has helped in their treatment. High growth in awareness about the disease along with adopting some other methods for overcoming the harmful effects has brought new opportunities for expanding the market size. Some of the other methods for diagnosing at an early rate and carrying out some of the alternatives for preventing future outbreaks have helped in boosting up the market growth during the upcoming global period. Challenges The outraging of various side effects have become some of the challenging factors for upsurging the market size. Unfavorable changes, certain regulations and some guidelines has caused a huge loss to the business where the market growth is being hampered. The change in healthcare infrastructure is a challenging factor whereas the timely medical care has become the challenging factor. Restraints the presence of life-threatening diseases of women has pushed down the healthcare women's health disease diagnosis market. Besides, the side effects caused by various drugs have deteriorated the women's health disease diagnosis and treatment market value and have had a bad effect on the health of the women. Likewise, consuming contraceptive pills in between the menstrual phase has brought various side effects like bleeding or spotting during the period days. The side effects also include sore breasts, headache, and many more like joint pain, heart attack, and stroke.  From the women's health disease diagnosis and treatment market outlook it was marked that all the above factors acted as a restraining factor deteriorating the market growth during the forecast period.

    The increasing prevalence of chronic diseases among women necessitates a comprehensive approach to diagnosis and treatment, highlighting the urgent need for tailored healthcare solutions.

    U.S. Department of Health and Human Services

    Women Health Disease Diagnosis Treatment Market Drivers

    Growing Awareness and Education

    The rising awareness and education surrounding women's health issues play a crucial role in shaping the Global Women Health Disease Diagnosis and Treatment Market Industry. Campaigns aimed at educating women about the importance of regular screenings and preventive care have gained momentum. Organizations and healthcare providers are increasingly focusing on outreach programs to inform women about potential health risks and available treatment options. This heightened awareness is expected to drive demand for diagnostic services and treatment modalities, contributing to the market's anticipated growth from 30.4 USD Billion in 2024 to 70.5 USD Billion by 2035, with a CAGR of 7.95% from 2025 to 2035.

    Chart Representation of Market Growth

    Advancements in Diagnostic Technologies

    Technological innovations in diagnostic tools significantly enhance the Global Women Health Disease Diagnosis and Treatment Market Industry. The introduction of advanced imaging techniques, such as 3D mammography and liquid biopsy, allows for earlier and more accurate detection of diseases. These advancements not only improve patient outcomes but also drive the adoption of new diagnostic solutions. As healthcare providers increasingly integrate these technologies into their practices, the market is expected to expand, aligning with the projected growth trajectory from 30.4 USD Billion in 2024 to 70.5 USD Billion by 2035, with a CAGR of 7.95% from 2025 to 2035.

    Increased Government Initiatives and Funding

    Government initiatives aimed at improving women's health significantly influence the Global Women Health Disease Diagnosis and Treatment Market Industry. Various countries are implementing policies to enhance healthcare access and funding for women's health programs. For example, the U.S. government has allocated substantial resources to support breast cancer research and awareness campaigns. Such initiatives not only promote early diagnosis and treatment but also foster collaboration among stakeholders, including healthcare providers and researchers. This supportive environment is likely to contribute to the market's growth, with projections indicating an increase from 30.4 USD Billion in 2024 to 70.5 USD Billion by 2035.

    Rising Prevalence of Women-Specific Diseases

    The increasing incidence of women-specific diseases, such as breast cancer and reproductive health disorders, drives the Global Women Health Disease Diagnosis and Treatment Market Industry. For instance, breast cancer remains the most common cancer among women globally, with an estimated 2.3 million new cases reported in 2020. This trend is likely to escalate, contributing to the market's projected growth from 30.4 USD Billion in 2024 to 70.5 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 7.95% from 2025 to 2035. The rising awareness and early detection initiatives further enhance the demand for diagnostic and treatment solutions.

    Market Segment Insights

    Women's Health Disease Diagnosis and Treatment Type Insights

    Get more detailed insights about Women Health Disease Diagnosis & Treatment Market Research Report- Forecast To 2032

    Key Companies in the Women Health Disease Diagnosis Treatment Market market include

    Industry Developments

    Ziqitza Healthcare in March 2020, carried out a certain women welfare program which helped the employees gain better treatment facilities. This wellness program helped them in optimizing their productivity and giving full importance to their own health. Torrent Pharmaceutical Ltd in May 2017, manufactured certain women drugs namely Regestrone and Pregachieve. These drugs were formed from Novartis AG, thus helping in expanding the product and their launching activities which helped in expanding their women's health disease diagnosis and treatment market growth. As of June 2021, Organon is the most important healthcare company dealing with the New York stock exchange dealing with women welfare facilities. Partners Group in May 2021, collaborated with a US-based Company. It helped in improving the patients' experience and their geographical outrage. Mitra Pharma along with the Mayne Pharma group in April 2021, gave approval for using oral contraceptives containing estetrol.   

    Future Outlook

    Women Health Disease Diagnosis Treatment Market Future Outlook

    The Women Health Disease Diagnosis and Treatment Market is projected to grow at a 7.95% CAGR from 2024 to 2035, driven by technological advancements, increasing awareness, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven diagnostic tools for early detection of women's health issues.
    • Expand telehealth services tailored for women's healthcare needs.
    • Invest in personalized treatment solutions leveraging genetic profiling for women.

    By 2035, the market is expected to achieve substantial growth, reflecting enhanced healthcare solutions for women.

    Report Scope

    Attribute/Metric Details
    Market Size 2023 27.83 (USD Billion)
    Market Size 2024 30.41 (USD Billion)
    Market Size 2032 57.16 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.26 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   General Electric Company (UK), CooperSurgical Inc. (US), ASCEND Therapeutics US, LLC. (US), Rinovum Women's Health, LLC. (US),
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Rise in number of women health disorders·  Increasing government expenditure·  Rise in awareness concerning women healthcare

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    What is the growth rate of the Women Health Disease Diagnosis & Treatment Market?

    The market is projected to grow at a CAGR of 7.26% during the forecast period, 2024-2032.

    Which region held the largest market share in the Women Health Disease Diagnosis & Treatment Market?

    North America had the largest share in the market.

    Who are the key players in the Women Health Disease Diagnosis & Treatment Market?

    The key players in the market are General Electric Company (UK), CooperSurgical Inc. (US), ASCEND Therapeutics US, LLC. (US), Rinovum Women's Health, LLC. (US)

    Women Health Disease Diagnosis & Treatment Market Research Report- Forecast To 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials